E

Elucid

AI-powered plaque analysis for cardiovascular imaging

Technical Lead - Imaging and AI Engineering

Backend EngineeringConfirmed live in the last 24 hours
Full-time$180k - $215k

About the Job

Requirements

  • At least 7 years of experience developing classical image processing algorithms and integrating them into commercial software.
  • Hands-on experience with CT/CTA or other volumetric medical imaging data, including segmentation and registration techniques, and familiarity with standards such as DICOM.
  • Strong modern C++ skills and a solid foundation in software design principles and patterns, including object-oriented design and template-based generic programming.
  • Experience optimizing software for performance, including algorithmic efficiency, memory usage, file I/O, and parallel execution, using techniques such as multithreading and profiling.
  • A track record of building maintainable production systems in collaborative, fast-paced engineering environments.

Responsibilities

  • Design classical image processing algorithms and own them through production.
  • Set technical direction for image processing architecture, mentor engineers, and influence design decisions across teams.
  • Build high-performance C++ pipelines and services to process large volumetric imaging datasets.
  • Partner with machine learning and visualization engineers to integrate work into the platform.

Desired Qualifications

  • CUDA or other GPU programming experience and familiarity with machine learning.

About the Company

Elucid

AI-powered plaque analysis for cardiovascular imaging

Elucid Bioimaging provides an AI-powered SaaS platform that helps clinicians diagnose and manage cardiovascular disease by analyzing coronary CT angiography images to quantify plaque and model the coronary arteries. PlaqueIQ uses machine learning trained on paired CCTA data and histology to identify plaque types, create a 3D artery model, and move toward non-invasive FFR measurements (FFRCT). The product stands out by using histology-grounded AI with FDA 510(k) clearance and CE marking, offering more detailed plaque characterization than many competitors. The company aims to expand sales in North America and Europe to enable precision cardiology and preventive treatment, with the goal of reducing heart attacks and strokes.

Company size
51-200
Company stage
Series D
Total funding
$183.3M
Headquarters
Boston, MA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Elucid

See more jobs